Angiogenesis and Inflammation in Invasive Carcinoma of the Breast

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1997 Aug 1

PMID 9301551

Citations 40

Authors

A H Lee

L C Happerfield

L G Bobrow

R R Millis

Affiliations

Soon will be listed here.

Abstract

Aim: To investigate the relation between angiogenesis and inflammation in invasive carcinoma of the breast.

Methods: Sections from 75 invasive carcinomas of the breast were stained using immunohistochemistry for von Willebrand factor, CD3, CD8, CD45RO, CD45RA, CD20, CD68, and c-erbB-2. Tumour vascularity was assessed by counting vessels in the three most vascular areas, and calculating the average (x 400 magnification, field 0.168 mm2). Each pattern of inflammation was scored semiquantitatively.

Results: The main pattern of inflammation was a diffuse infiltrate of macrophages, and to a lesser extent T cells. Perivascular and perilobular clusters of B and T cells were noted at the edge of the carcinomas, but were less prominent than the diffuse inflammation. Diffuse inflammation, particularly macrophages, was associated with high tumour grade, tumour necrosis, large tumour size, and c-erbB-2 expression. Perivascular and perilobular inflammation also increased with tumour grade. Tumour vascularity increased slightly with intensity of diffuse inflammation (Spearman's rank correlation coefficient rs = 0.17, p = 0.08), and was inversely related to perilobular inflammation (rs = -0.23, p = 0.03).

Conclusions: The correlations between inflammation and vascularity were weak in this study (r2 about 0.04) and thus there was no evidence of an important relation. Discrepancies between this and other studies may be resolved by studying expression of angiogenic cytokines and proteolytic enzymes by tumour infiltrating inflammatory cells, and their relation to tumour vascularity.

Citing Articles

Artificial intelligence: illuminating the depths of the tumor microenvironment.

Xie T, Huang A, Yan H, Ju X, Xiang L, Yuan J J Transl Med. 2024; 22(1):799.

PMID: 39210368 PMC: 11360846. DOI: 10.1186/s12967-024-05609-6.

Challenges and Opportunities Modeling the Dynamic Tumor Matrisome.

Peyton S, Platt M, Cukierman E BME Front. 2023; 4:0006.

PMID: 37849664 PMC: 10521682. DOI: 10.34133/bmef.0006.

cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment.

Mishra S, Charan M, Shukla R, Agarwal P, Misri S, Verma A J Exp Clin Cancer Res. 2022; 41(1):54.

PMID: 35135586 PMC: 8822829. DOI: 10.1186/s13046-021-02221-0.

miR-182 targeting reprograms tumor-associated macrophages and limits breast cancer progression.

Ma C, He D, Tian P, Wang Y, He Y, Wu Q Proc Natl Acad Sci U S A. 2022; 119(6).

PMID: 35105806 PMC: 8833194. DOI: 10.1073/pnas.2114006119.

Tumor-associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer.

Chen Y, Audun Klingen T, Aas H, Wik E, Akslen L J Pathol Clin Res. 2021; 7(5):517-527.

PMID: 34076969 PMC: 8363927. DOI: 10.1002/cjp2.226.

References

Koch A, Polverini P, Leibovich S . Induction of neovascularization by activated human monocytes. J Leukoc Biol. 1986; 39(2):233-8. DOI: 10.1002/jlb.39.2.233. View

Gottlinger H, Rieber P, Gokel J, Lohe K, Riethmuller G . Infiltrating mononuclear cells in human breast carcinoma: predominance of T4+ monocytic cells in the tumor stroma. Int J Cancer. 1985; 35(2):199-205. DOI: 10.1002/ijc.2910350210. View

Zuk J, Walker R . Immunohistochemical analysis of HLA antigens and mononuclear infiltrates of benign and malignant breast. J Pathol. 1987; 152(4):275-85. DOI: 10.1002/path.1711520406. View

Kelly P, Davison R, Bliss E, Mcgee J . Macrophages in human breast disease: a quantitative immunohistochemical study. Br J Cancer. 1988; 57(2):174-7. PMC: 2246436. DOI: 10.1038/bjc.1988.36. View

Balch C, Riley L, Bae Y, Salmeron M, Platsoucas C, von Eschenbach A . Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg. 1990; 125(2):200-5. DOI: 10.1001/archsurg.1990.01410140078012. View

RILKE F, Colnaghi M, Cascinelli N, Andreola S, Baldini M, Bufalino R . Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int J Cancer. 1991; 49(1):44-9. DOI: 10.1002/ijc.2910490109. View

Elston C, Ellis I . Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991; 19(5):403-10. DOI: 10.1111/j.1365-2559.1991.tb00229.x. View

Aaltomaa S, Lipponen P, Eskelinen M, Kosma V, Marin S, Alhava E . Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer. 1992; 28A(4-5):859-64. DOI: 10.1016/0959-8049(92)90134-n. View

Horak E, Leek R, Klenk N, Lejeune S, Smith K, Stuart N . Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet. 1992; 340(8828):1120-4. DOI: 10.1016/0140-6736(92)93150-l. View

10.

Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred E, Moore D . Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst. 1992; 84(24):1875-87. DOI: 10.1093/jnci/84.24.1875. View

11.

OLaughlin S, Braverman M, Buckley P . Macrophages (histiocytes) in various reactive and inflammatory conditions express different antigenic phenotypes. Hum Pathol. 1992; 23(12):1410-8. DOI: 10.1016/0046-8177(92)90062-8. View

12.

Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C . Macrophages and angiogenesis. J Leukoc Biol. 1994; 55(3):410-22. DOI: 10.1002/jlb.55.3.410. View

13.

Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T . Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer. 1995; 64(2):79-82. DOI: 10.1002/ijc.2910640202. View

14.

Hildenbrand R, Dilger I, Horlin A, STUTTE H . Urokinase and macrophages in tumour angiogenesis. Br J Cancer. 1995; 72(4):818-23. PMC: 2034060. DOI: 10.1038/bjc.1995.419. View

15.

Visscher D, Demattia F, Ottosen S, Sarkar F, Crissman J . Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. Mod Pathol. 1995; 8(6):665-70. View

16.

Toi M, Inada K, Suzuki H, Tominaga T . Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat. 1995; 36(2):193-204. DOI: 10.1007/BF00666040. View

17.

Fox S, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse R . The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer. 1996; 73(3):275-80. PMC: 2074437. DOI: 10.1038/bjc.1996.49. View

18.

Lee A, Happerfield L, Millis R, Bobrow L . Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast. Br J Cancer. 1996; 74(5):796-801. PMC: 2074701. DOI: 10.1038/bjc.1996.438. View

19.

Visscher D, Tabaczka P, Long D, Crissman J . Clinicopathologic analysis of macrophage infiltrates in breast carcinoma. Pathol Res Pract. 1995; 191(11):1133-9. DOI: 10.1016/S0344-0338(11)80658-8. View

20.

Leek R, Lewis C, Whitehouse R, Greenall M, Clarke J, Harris A . Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996; 56(20):4625-9. View